Discussing axSpA: Comparative real-world effectiveness of biologic and targeted therapies in axSpA
The IMID Forum
- Published
- September 18, 2025
- Duration
- 20:52
- Summary source
- description
- Last updated
- Jun 21, 2026
Discusses Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the wo…
Summary
Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered the effectiveness of ixekizumab in real-world patients with axSpA and PsA, and the real‑world comparison of clinical effectiveness of UPA, TNF inhibitors or IL‑17 inhibitors in patients with axSpA after swi…
Intelligent report
Sign in to read teasers, or upgrade to Research Pro to commission a new dossier for this episode. Learn more →
Show notes
Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered the effectiveness of ixekizumab in real-world patients with axSpA and PsA, and the real‑world comparison of clinical effectiveness of UPA, TNF inhibitors or IL‑17 inhibitors in patients with axSpA after switching from an initial TNF inhibitor.